Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
---|
03/22/2007 | US20070066585 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
03/22/2007 | CA2621364A1 Biphenyl derivatives and their use in treating hepatitis c |
03/22/2007 | CA2619061A1 Fungicide pyridinyloxy substituted phenylamidine derivatives |
03/21/2007 | EP1764361A1 Crystal of 1,2-dihydropyridine compound and method for producing same |
03/21/2007 | EP1764358A2 Cyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain |
03/21/2007 | EP1764096A1 Novel phloroglucinol derivatives having selectin ligand activity |
03/21/2007 | EP1764095A1 Novel nitrocatechol derivatives having selectin ligand activity |
03/21/2007 | EP1763514A2 Cycloalkyl substituted pyrimidinediamine compounds and their uses |
03/21/2007 | EP1763513A1 Bi- or tetra-guanidino-biphenyl compounds as small molecule carriers |
03/21/2007 | EP1763511A1 Phenoxyacetic acid derivatives as ppar agonists |
03/21/2007 | EP1763502A1 Novel hexafluoroisopropanol derivatives |
03/21/2007 | EP1763302A2 Chemical compounds |
03/21/2007 | EP1453801B1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
03/21/2007 | EP0817643B1 Compounds and compositions for delivering active agents |
03/21/2007 | CN1934097A Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists |
03/21/2007 | CN1934085A Vapor phase catalytic chlorination of beta-picoline |
03/21/2007 | CN1934084A Process for preparing diimine compounds |
03/21/2007 | CN1934074A Fungicidal phenoxyphenylhydrazine derivatives |
03/21/2007 | CN1933853A Drug conjugates |
03/21/2007 | CN1933839A Compounds and methods of use |
03/21/2007 | CN1933808A Composition comprising a monomer compound exhibiting an optical property, method making use of said composition, a monomer compound, a polymer containing said monomer compound and the use thereof |
03/21/2007 | CN1931844A Prepn process of copper nicotinate |
03/21/2007 | CN1931843A Alkali metal salt of 6-substituted amino-3,5-dihalogeno-2-pyridol and its prepn and application |
03/21/2007 | CN1931842A Prepn process of tenatoprazole and its starting compound |
03/21/2007 | CN1931841A Synthesis process of 4,4'-dimethyl-2,2'-bipyridine |
03/21/2007 | CN1931839A Synthesis process of N-substituted pyrrole |
03/21/2007 | CN1306017C Use of metal complex compounds as oxidation catalysts |
03/21/2007 | CN1305852C Diaryl ethers as opioid receptor antagonist |
03/21/2007 | CN1305851C N-allyl-2-alkyl pyridinium chloride onium salt, its homopolymer and copolymer, and its preparation method |
03/21/2007 | CN1305850C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
03/21/2007 | CN1305846C Novel urea derivatives |
03/21/2007 | CN1305475C Boronic ester and acid compounds, synthesis and uses |
03/20/2007 | US7193087 4-Aminopyridinium compound |
03/20/2007 | US7192983 N-protected/N-substituted-beta-amino hydroxy sulfonates |
03/20/2007 | US7192982 Modulators of peroxisome proliferator activated receptors |
03/20/2007 | CA2220094C Process for producing guanidine derivatives, intermediates therefor and their production |
03/15/2007 | WO2007029696A1 Electron transporting material and organic electroluminescent device using the same |
03/15/2007 | WO2007029036A2 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
03/15/2007 | WO2007028456A1 Substituted pyridocarboxamides as inhibitors of plasminogen activator inhibitor 1 (pai-1) |
03/15/2007 | WO2007028424A1 Amide derivatives as ppar activators |
03/15/2007 | WO2007016674A3 2-aminoaryl pyridines as protein kinases inhibitors |
03/15/2007 | WO2006110276A3 Acylated thiosemicarbazides as herbicides |
03/15/2007 | WO2006083477A3 Compounds for inflammation and immune-related uses |
03/15/2007 | US20070060748 Compounds with mixed pde-inhibitory and beta-adrenergic antagonist or partial agonist activity for treatment of heart failure |
03/15/2007 | US20070060624 Novel bioisosteres of actinonin |
03/15/2007 | US20070060619 Nicotinamide-based kinase inhibitors |
03/15/2007 | US20070060618 Alkyne derivatives as tracers for metabotropic glutamate receptor binding |
03/15/2007 | US20070060587 Indane derivates as muscarinic receptor agonists |
03/15/2007 | US20070060572 e.g., 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine; mitogen-activated protein kinase inhibitor; antiinflammatory agent, autoimmune diseases |
03/15/2007 | US20070060480 Heteroaroyl-substituted phenylalanineamides |
03/15/2007 | US20070059633 Dissolving a pi complex of tetramethylcyclopentadienyl 2,2'-bipyridin-1,1'-diyl iridium hydride in a solvent; irrradiating with a laser beam to deprotonate and produce an acidicsolution; chemically-amplified photoresists; color filters for liquid rystal; photography/printing; solubility; efficiency |
03/15/2007 | CA2621445A1 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
03/15/2007 | CA2621406A1 Pparactive compounds |
03/15/2007 | CA2620491A1 Pharmaceutical dosage forms and compositions comprising lecoztan |
03/15/2007 | CA2615888A1 Substituted pyridocarboxamides as inhibitors of plasminogen activator inhibitor 1 (pai-1) |
03/15/2007 | CA2597148A1 Amide derivatives as ppar activators |
03/14/2007 | EP1761516A1 2, 4, 5, 6-substituted pyrimidines, method for the production and use thereof for combating parasitic fungi |
03/14/2007 | EP1761496A2 Non-imidazole heterocyclic compounds as histamine h3-receptor ligands |
03/14/2007 | EP1565433B1 Novel ligands that are antagonists of rar receptors, process for preparing them and use thereof in human medicine and in cosmetics |
03/14/2007 | EP1562936B1 Therapeutic piperazine compounds |
03/14/2007 | EP1246802B1 4-aminopicolinates and their use as herbicides |
03/14/2007 | EP1040103B1 Anilide derivative, production and use thereof |
03/14/2007 | CN1930139A Derivatives of hydroxamic acid as metalloproteinase inhibitors |
03/14/2007 | CN1930126A 吡啶酮衍生物 Pyridine derivatives |
03/14/2007 | CN1930121A Substituted heteroaryl- and phenylsulfamoyl compounds |
03/14/2007 | CN1930105A Method for preparation of a fluoroaromatic compound from an aminoaromatic amine compound |
03/14/2007 | CN1929920A Use of metal complex compounds comprising pyridine, pyrimidine or S-triazine derived ligands as catalysts for oxidations with organic peroxy acids and/or precursors of organic peroxy acids and H2O2 |
03/14/2007 | CN1927843A Compound of 2-substituted alkylacrylate and application thereof |
03/14/2007 | CN1927839A Compound of 1,4-di(arylamido substituted alkylamino)-5,8-dihydroxyanthraquinone and preparation method thereof |
03/14/2007 | CN1927838A Compound of N-(substituted pyridyl)amide, preparation and application thereof |
03/14/2007 | CN1927831A N-sulfenate group diaromatic hydrazide derivative, preparation and application thereof |
03/14/2007 | CN1304372C Tri-substituted phenyl derivates useful as PDE IV inhibitors |
03/14/2007 | CN1304365C Acylated arylcycloalkylamines and their use as pharmaceuticals |
03/13/2007 | US7189865 Thiomolybdate analogues and uses thereof |
03/13/2007 | US7189864 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde; efficient synthesis of intermediates which are readily amenable to the large scale preparation of hydroxyethylurea-based chiral HIV protease inhibitors |
03/13/2007 | US7189855 Process for production of phenoxy-substituted 2-pyridone compounds |
03/13/2007 | US7189854 Reacting 4-(2-hydroxyethyl)piperazine and 2-((2-methyl,6-chloro-pyrimidin-4-yl)-amino),5-(2-chloro,6-methyl-phenyl)thiazole to obtain 2-((2-hydroxyethyl)piperazin-4-yl)-(2-methylpyrimidin-6,4-ylene)amino-),5-(2-chloro,6-methyl-phenyl)thiazole; antiarthritic,-tumor, -carcinogentic agents; immunology |
03/13/2007 | US7189757 Sleep disorders; side effect reduction |
03/13/2007 | US7189728 Inhibitors of dipeptidyl peptidase IV |
03/13/2007 | CA2398182C Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
03/13/2007 | CA2315227C Arylpiperazines having activity at the serotonin 1a receptor |
03/13/2007 | CA2295106C 3-anilino-2-cycloalkenone derivatives |
03/13/2007 | CA2112866C Novel derivatives of 2-cyano-3-hydroxy-propenamides, a process for their preparation, their application as medicaments and pharmaceutical compositions containing them |
03/08/2007 | WO2007027651A2 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
03/08/2007 | WO2007027599A1 9-aminocarbonylsubstituted derivatives of glycylcyclines |
03/08/2007 | WO2007027528A2 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-.receptor tyrosine kinases |
03/08/2007 | WO2007027468A1 Ep2 receptor agonists for treating glaucoma |
03/08/2007 | WO2007026920A2 Amide derivatives as rock inhibitors |
03/08/2007 | WO2007026609A1 Polymer-supported palladium catalyst and method for production thereof |
03/08/2007 | WO2007026312A1 1,3-diaminobenzene derivatives and colorants comprising these compounds |
03/08/2007 | WO2007025709A2 Organic compounds |
03/08/2007 | WO2007025575A1 O-hydroxy- and o-amino benzamide derivatives as ikk2 inhibitors |
03/08/2007 | WO2006097489A8 Biphenyl-n-(4-pyridyl) methylsufonamides |
03/08/2007 | US20070054945 4-amino-3-(4-chlorophenyl)butanoic acid; prodrugs of baclofen and baclofen analogs; gamma aminobutanoic acid agonist; drug, nicotine, and narcotic abuse; antitussive, antiemetic agent; cough, nausea, vomiting; oral administration; sustained release dosage form |
03/08/2007 | US20070054944 Pharmaceutical compositions comprising 1-isopropyl-3-[ (4-M-toluidino-3-pyridyl) sulphonyl] -urea as active ingredient |
03/08/2007 | US20070054921 Substituted indoles and a process for preparing substituted indoles |
03/08/2007 | US20070054918 N-[(piperazinyl)hetary]arylsulfonamide compounds with affinity for the dopamine d3 receptor |
03/08/2007 | US20070054909 VLA-4 inhibitor compounds |
03/08/2007 | US20070054904 Phenol derivatives and their use as rotamase inhibitors |
03/08/2007 | US20070054897 1,1-Dicyclohexyl-3-thiazol-2-yl-urea, 3-(5-Chloro-thiazol-2-yl)-1,1-dicyclohexyl-urea, for example; useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial, in particular, type 2 diabetes |